Last reviewed · How we verify
Ringer Lactate and Norepinephrine infusion
At a glance
| Generic name | Ringer Lactate and Norepinephrine infusion |
|---|---|
| Sponsor | Tata Memorial Centre |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery (NA)
- Effect of a FLUid Bolus or a Low Dose VAsopressor Infusion on Cardiovascular Collapse Among Critically Ill Adults Undergoing Tracheal Intubation. (NA)
- Fluid Therapy and Glycocalyx Shedding During Moderate Surgery (NA)
- The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock (PHASE2, PHASE3)
- Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (PHASE3)
- Cardiac Responsiveness Assessment by CO2
- Comparison of Liberal and Restrictive Fluid Management on the Endothelial Glycocalyx in Radical Cystectomy (NA)
- The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: